BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 27374736)

  • 1. Assessing abortion coverage in nurse practitioner programs in Canada: a national survey of program directors.
    Sheinfeld L; Arnott G; El-Haddad J; Foster AM
    Contraception; 2016 Nov; 94(5):483-488. PubMed ID: 27374736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abortion education in nurse practitioner, physician assistant and certified nurse-midwifery programs: a national survey.
    Foster AM; Polis C; Allee MK; Simmonds K; Zurek M; Brown A
    Contraception; 2006 Apr; 73(4):408-14. PubMed ID: 16531177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abortion-care education in Japanese nurse practitioner and midwifery programs: a national survey.
    Mizuno M
    Nurse Educ Today; 2014 Jan; 34(1):11-4. PubMed ID: 23683888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Provision of first-trimester medication abortion in 2019: Results from the Canadian abortion provider survey.
    Ennis M; Renner R; Guilbert E; Norman WV; Pymar H; Kean L; Carson A; Martin-Misener R; Dunn S
    Contraception; 2022 Sep; 113():19-25. PubMed ID: 35351448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring Canadian women's knowledge of and interest in mifepristone: results from a national qualitative study with abortion patients.
    Vogel KI; LaRoche KJ; El-Haddad J; Chaumont A; Foster AM
    Contraception; 2016 Aug; 94(2):137-42. PubMed ID: 27125893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ob/Gyn training in abortion care: results from a national survey.
    Jackson CB; Foster AM
    Contraception; 2012 Oct; 86(4):407-12. PubMed ID: 22560184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "It gives you autonomy over your own choices": A qualitative study of Canadian abortion patients' experiences with mifepristone and misoprostol.
    LaRoche KJ; Foster AM
    Contraception; 2020 Jul; 102(1):61-65. PubMed ID: 32304768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abortion training in Canadian obstetrics and gynecology residency programs.
    Liauw J; Dineley B; Gerster K; Hill N; Costescu D
    Contraception; 2016 Nov; 94(5):478-482. PubMed ID: 27452315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postgraduate Experiences With an Advanced Reproductive Health and Abortion Training and Leadership Program.
    Block A; Dehlendorf C; Biggs MA; McNeil S; Goodman S
    Fam Med; 2017 Oct; 49(9):706-713. PubMed ID: 29045988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second- and Third-Trimester Medical Abortion Providers and Services in 2019: Results From the Canadian Abortion Provider Survey.
    Renner R; Ennis M; Guilbert E; Roy G; Barrett J
    J Obstet Gynaecol Can; 2022 Jun; 44(6):690-699. PubMed ID: 35183788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barriers and enablers to nurse practitioner implementation of medication abortion in Canada: A qualitative study.
    Carson A; Stirling-Cameron E; Paynter M; Munro S; Norman WV; Kilpatrick K; Begun S; Martin-Misener R
    PLoS One; 2023; 18(1):e0280757. PubMed ID: 36701296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curriculum trends in nurse practitioner programs: current and ideal.
    Bellack JP; Graber DR; O'Neil EH; Musham C; Lancaster C
    J Prof Nurs; 1999; 15(1):15-27. PubMed ID: 9951196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "We've got rights and yet we don't have access": Exploring patient experiences accessing medication abortion in Australia.
    LaRoche KJ; Wynn LL; Foster AM
    Contraception; 2020 Apr; 101(4):256-260. PubMed ID: 31927029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First impressions: what are preclinical medical students in the US and Canada learning about sexual and reproductive health?
    Steinauer J; LaRochelle F; Rowh M; Backus L; Sandahl Y; Foster A
    Contraception; 2009 Jul; 80(1):74-80. PubMed ID: 19501219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in medication abortion provision before and after the introduction of mifepristone: A study of the National Abortion Federation's Canadian member services.
    Yalahow A; Doctoroff J; Mark A; Foster AM
    Contraception; 2020 Aug; 102(2):119-121. PubMed ID: 32325077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience of stigma and harassment among respondents to the 2019 Canadian abortion provider survey.
    Ennis M; Renner RM; Olure B; Norman WV; Begun S; Martin L; Harris LH; Kean L; Seewald M; Munro S
    Contraception; 2023 Aug; 124():110083. PubMed ID: 37263373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating mifepristone into primary care in Canada's capital: A multi-methods exploration of the Medical Abortion Access Project.
    LaRoche KJ; Wylie A; Persaud M; Foster AM
    Contraception; 2022 May; 109():37-42. PubMed ID: 35031301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inclusion of disability-related content in nurse practitioner curricula.
    Smeltzer SC; Blunt E; Marozsan H; Wetzel-Effinger L
    J Am Assoc Nurse Pract; 2015 Apr; 27(4):213-21. PubMed ID: 24948029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nurse practitioners on 'the leading edge' of medication abortion care: A feminist qualitative approach.
    Carson A; Cameron ES; Paynter M; Norman WV; Munro S; Martin-Misener R
    J Adv Nurs; 2023 Feb; 79(2):686-697. PubMed ID: 36369652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations Between Program-Level Abortion Training and Graduate Preparation for and Provision of Reproductive Care.
    Weidner A; Stevens N; Shih G
    Fam Med; 2019 Oct; 51(9):750-755. PubMed ID: 31596932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.